PharmaEssentia revenue and financials
In the fiscal year ended December 2025, PharmaEssentia reported revenue of $15.63B (+60.61% year over year). Net income was $5.05B, a net margin of 32.3%.
Fiscal year ending in December. Sources and method on the page How we analyse stocks.
At a glance
- Revenue growth
- +60.61%
- 2025 vs 2024
- Net income growth
- +70.13%
- 2025 vs 2024
- Net margin
- 32.3%
- 2024: 30.5%
How PharmaEssentia is changing
Calculated from the annual statements; each fiscal year is labelled with the year it ends.
Revenue grew 94.8% a year on average over the last 5 years
Compound annual growth rate: from $557.26M in 2020 to $15.63B in 2025.
Revenue has grown for 8 fiscal years in a row
Each fiscal year compared with the one before, up to 2025.
Operating margin rose from −70.4% to 31.5%
Operating income over revenue, 2022 → 2025: 101.9 percentage points.
Less cash than profit: free cash flow equal to 41% of net income
Totals for fiscal years 2023–2025: free cash flow $3.03B, net income $7.39B.
Shares outstanding up 38.1% in 5 years
Average diluted shares, 2020 → 2025: with more shares, each one represents a smaller stake in the company (dilution).
Profitable in 2 of 5 fiscal years
Positive net income, fiscal years 2021–2025.
Financial data
Amounts in millions of TWD; per-share values in TWD; shares in millions.
| Item | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 15,635 | 9,735 | 5,106 | 2,882 | 657 | 557 | 306 | 26.2 | 4.0 | 5.5 |
| Cost of revenue | 1,684 | 1,177 | 611 | 812 | 379 | 373 | 61.7 | 28.4 | -0.3 | 1.1 |
| Gross profit | 13,950 | 8,558 | 4,495 | 2,070 | 278 | 184 | 244 | -2.2 | 4.3 | 4.3 |
| Selling, general and administrative | 5,554 | 4,234 | 4,184 | 2,672 | 1,827 | 977 | 454 | 267 | 210 | 167 |
| Research and development | 3,468 | 2,588 | 2,224 | 1,426 | 1,273 | 922 | 640 | 786 | 683 | 686 |
| Operating income | 4,928 | 1,736 | -1,913 | -2,028 | -2,822 | -1,716 | -849 | -1,055 | -889 | -849 |
| EBIT | 4,928 | 1,736 | -1,913 | -2,028 | -2,822 | -1,716 | -849 | -1,055 | -889 | -849 |
| EBITDA | 5,061 | 1,847 | -1,824 | -1,912 | -2,703 | -1,621 | -775 | -998 | -827 | -787 |
| Interest expense | 25.5 | 22.2 | 46.7 | 18.5 | 10.0 | 8.3 | 7.5 | 1.6 | 1.8 | 1.9 |
| Pre-tax income | 4,983 | 2,995 | -987 | -1,842 | -2,811 | -1,948 | -842 | -1,039 | -872 | -845 |
| Income tax | -62.2 | 29.1 | -363 | -467 | — | 0.1 | 0.9 | 0.6 | — | — |
| Net income | 5,045 | 2,966 | -624 | -1,375 | -2,811 | -1,948 | -843 | -1,040 | -872 | -845 |
| Net income to common shareholders | 5,045 | 2,966 | -624 | -1,375 | -2,811 | -1,948 | -843 | -1,040 | -872 | -845 |
| Basic EPS | 12.30 | 7.27 | -1.57 | -3.93 | -8.78 | -6.53 | -3.13 | -3.87 | -3.25 | -3.36 |
| Diluted EPS | 12.25 | 7.21 | -1.57 | -3.93 | -8.78 | -6.53 | -3.13 | -3.87 | -3.25 | -3.36 |
| Average shares (basic) | 410 | 408 | 397 | 350 | 320 | 298 | 270 | 269 | 268 | 251 |
| Average shares (diluted) | 412 | 411 | 397 | 350 | 320 | 298 | 270 | 269 | 268 | 251 |
| Dividend per share | 1.35 | 0.89 | — | — | — | — | — | — | — | — |
Amounts in millions of TWD; per-share values in TWD; shares in millions.
| Item | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 6,855 | 5,121 | 4,881 | 3,894 | 3,602 | 3,257 | 3,062 | 2,713 | 2,306 | 1,653 | 1,647 | 1,306 |
| Cost of revenue | 395 | 621 | 544 | 328 | 450 | 363 | 356 | 328 | 300 | 193 | 252 | 122 |
| Gross profit | 6,460 | 4,500 | 4,338 | 3,566 | 3,152 | 2,895 | 2,706 | 2,385 | 2,006 | 1,460 | 1,395 | 1,184 |
| Selling, general and administrative | 2,238 | 1,556 | 1,769 | 1,515 | 1,228 | 1,042 | 1,397 | 948 | 970 | 919 | 955 | 1,044 |
| Research and development | 1,067 | 857 | 1,007 | 885 | 829 | 747 | 768 | 703 | 593 | 524 | 572 | 786 |
| Operating income | 3,152 | 2,087 | 1,561 | 1,166 | 1,096 | 1,105 | 541 | 735 | 443 | 17.6 | -132 | -645 |
| EBIT | 3,152 | 2,087 | 1,561 | 1,166 | 1,096 | 1,105 | 541 | 735 | 443 | 17.6 | -132 | -645 |
| EBITDA | 3,206 | 2,137 | 1,600 | 1,199 | 1,126 | 1,136 | 570 | 762 | 470 | 44.5 | -105 | -625 |
| Interest expense | 6.0 | 4.7 | 5.8 | 5.6 | 8.8 | 5.4 | 5.3 | 5.6 | 6.2 | 5.1 | 6.0 | 3.9 |
| Pre-tax income | 3,199 | 2,336 | 2,013 | 1,414 | 95.8 | 1,460 | 852 | 881 | 927 | 335 | -215 | 191 |
| Income tax | 669 | 186 | 536 | -59.2 | -736 | 197 | -384 | 162 | 247 | 4.2 | -331 | -7.7 |
| Net income | 2,530 | 2,150 | 1,476 | 1,473 | 832 | 1,264 | 1,236 | 720 | 680 | 330 | 116 | 199 |
| Net income to common shareholders | 2,530 | 2,150 | 1,476 | 1,473 | 832 | 1,264 | 1,236 | 720 | 680 | 330 | 116 | 199 |
| Basic EPS | 6.13 | 5.22 | 3.59 | 3.59 | 2.03 | 3.09 | 3.03 | 1.79 | 1.70 | 0.81 | 0.29 | 0.54 |
| Diluted EPS | 6.13 | 5.21 | 3.58 | 3.58 | 2.02 | 3.07 | 3.00 | 1.78 | 1.68 | 0.80 | 0.29 | 0.54 |
| Average shares (basic) | 413 | 412 | 411 | 410 | 410 | 409 | 408 | 401 | 400 | 407 | 406 | 367 |
| Average shares (diluted) | 413 | 413 | 412 | 411 | 412 | 411 | 412 | 404 | 404 | 411 | 406 | 372 |
| Dividend per share | — | — | 1.35 | — | — | — | 0.89 | — | — | — | — | — |
Amounts in millions of TWD; per-share values in TWD; shares in millions.
| Item | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | 37,411 | 31,062 | 27,269 | 15,333 | 6,198 | 5,531 | 2,959 | 2,805 | 3,669 | 4,499 |
| Current assets | 29,044 | 25,417 | 22,896 | 13,375 | 4,927 | 4,147 | 1,919 | 2,263 | 3,259 | 4,086 |
| Cash and equivalents | 22,693 | 21,051 | 19,666 | 10,304 | 3,454 | 3,200 | 1,396 | 2,167 | 3,186 | 4,044 |
| Short-term investments | 0.4 | 23.6 | 22.2 | 976 | — | 12.0 | — | — | — | — |
| Receivables | 4,649 | 2,834 | 1,548 | 840 | 493 | 453 | 200 | 24.2 | 1.4 | 2.4 |
| Inventory | 1,328 | 1,287 | 1,459 | 1,102 | 861 | 395 | 255 | 33.5 | 57.5 | 28.5 |
| Net property, plant and equipment | 4,902 | 3,361 | 2,733 | 1,018 | 765 | 892 | 734 | 308 | 245 | 288 |
| Other intangible assets | 235 | 273 | 268 | 237 | 246 | 221 | 98.2 | 16.5 | 16.4 | 17.8 |
| Long-term investments | 461 | 542 | 164 | 43.2 | 39.2 | 95.2 | 24.3 | — | — | — |
| Current liabilities | 4,681 | 2,557 | 2,152 | 2,550 | 1,412 | 1,087 | 337 | 245 | 118 | 128 |
| Accounts payable | 157 | 126 | 129 | 231 | 176 | 177 | 31.4 | 18.0 | 14.5 | 12.2 |
| Long-term debt | 44.8 | 50.8 | 62.7 | 75.0 | 87.1 | 99.2 | 78.3 | 84.1 | 89.9 | 95.7 |
| Total debt | 856 | 965 | 1,179 | 575 | 516 | 597 | 424 | 89.9 | 95.7 | 102 |
| Total liabilities | 5,436 | 3,593 | 3,321 | 3,191 | 1,948 | 1,611 | 704 | 333 | 212 | 228 |
| Total equity (incl. minority) | 31,975 | 27,469 | 23,948 | 12,141 | 4,250 | 3,920 | 2,255 | 2,472 | 3,457 | 4,270 |
| Retained earnings | 7,244 | 2,974 | -631 | -4,186 | -2,811 | -2,144 | -844 | -1,012 | -873 | -2,175 |
Amounts in millions of TWD; per-share values in TWD; shares in millions.
| Item | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | 44,111 | 40,090 | 37,411 | 34,450 | 32,804 | 33,024 | 31,062 | 29,145 | 28,195 | 27,235 | 27,269 | 26,880 |
| Current assets | 33,589 | 30,923 | 29,044 | 26,842 | 25,771 | 26,899 | 25,417 | 24,698 | 23,813 | 22,844 | 22,896 | 23,903 |
| Cash and equivalents | 24,471 | 24,175 | 22,693 | 21,581 | 20,783 | 22,034 | 21,051 | 20,832 | 20,060 | 19,192 | 19,666 | 20,533 |
| Short-term investments | 24.2 | 24.3 | 0.4 | 0.4 | 22.0 | 24.2 | — | — | — | — | — | — |
| Receivables | 5,849 | 4,883 | 4,649 | 3,758 | 3,417 | 3,118 | 2,834 | 2,315 | 2,236 | 1,937 | 1,548 | 1,581 |
| Inventory | 1,314 | 1,269 | 1,328 | 1,182 | 1,171 | 1,398 | 1,287 | 1,270 | 1,268 | 1,458 | 1,459 | 1,532 |
| Net property, plant and equipment | 5,819 | 5,232 | 4,902 | 4,035 | 3,797 | 3,605 | 3,361 | 3,050 | 2,937 | 2,794 | 2,733 | 1,672 |
| Goodwill | 880 | — | — | — | — | — | — | — | — | — | — | — |
| Other intangible assets | 431 | 224 | 235 | 245 | 260 | 270 | 273 | 252 | 262 | 257 | 268 | 265 |
| Long-term investments | 428 | 428 | 461 | 472 | 502 | 640 | 542 | 120 | 154 | 161 | 164 | 166 |
| Current liabilities | 6,364 | 4,737 | 4,681 | 3,928 | 3,342 | 2,967 | 2,557 | 2,007 | 1,863 | 1,833 | 2,152 | 2,178 |
| Accounts payable | 337 | 144 | 157 | 200 | 146 | 189 | 126 | 131 | 149 | 131 | 129 | 122 |
| Long-term debt | 41.8 | 43.3 | 44.8 | 46.3 | 47.8 | 49.3 | 50.8 | 53.4 | 56.5 | 59.6 | 62.7 | 65.8 |
| Total debt | 1,022 | 961 | 856 | 893 | 944 | 985 | 965 | 1,022 | 1,077 | 1,128 | — | — |
| Total liabilities | 7,295 | 5,635 | 5,436 | 4,701 | 4,259 | 3,900 | 3,593 | 3,060 | 2,876 | 2,821 | 3,321 | 3,032 |
| Total equity (incl. minority) | 36,816 | 34,454 | 31,975 | 29,749 | 28,545 | 29,123 | 27,469 | 26,084 | 25,319 | 24,413 | 23,948 | 23,848 |
| Retained earnings | 10,550 | 9,394 | 7,244 | 5,769 | 4,296 | 4,237 | 2,974 | 1,737 | 1,010 | -301 | -631 | -740 |
Amounts in millions of TWD; per-share values in TWD; shares in millions.
| Item | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | 5,278 | 2,525 | -710 | -1,505 | -2,462 | -1,455 | -945 | -827 | -790 | -657 |
| Depreciation and amortization | 352 | 337 | 251 | 225 | 226 | 174 | 137 | 57.3 | 62.3 | 61.6 |
| Capital expenditure | -1,911 | -862 | -1,286 | -312 | -70.3 | -81.2 | -121 | -146 | -25.4 | -22.8 |
| Investing cash flow | -2,475 | -1,335 | -487 | -1,243 | -78.2 | -302 | -238 | -189 | -61.7 | -29.0 |
| Financing cash flow | -500 | -163 | 10,454 | 9,579 | 2,809 | 3,566 | 411 | -3.7 | -4.9 | 4,167 |
| Dividends paid | -366 | — | — | — | — | — | — | — | — | — |
| Share repurchases | — | 0.0 | -2,718 | 0.0 | -87.5 | -257 | -2.0 | -2.1 | -3.0 | -0.1 |
| Debt issued | 2,243 | 0.0 | 1.0 | 974 | — | 75.0 | — | — | — | — |
| Debt repaid | -2,472 | -254 | -1,125 | -127 | -146 | -86.7 | -77.3 | -5.8 | -5.8 | -5.8 |
| Effect of exchange rates | -661 | 358 | 104 | 19.0 | -15.2 | -4.2 | 0.2 | 0.3 | -1.4 | -0.8 |
| Net change in cash | 1,642 | 1,385 | 9,362 | 6,850 | 253 | 1,805 | -771 | -1,019 | -858 | 3,480 |
| Free cash flow | 3,366 | 1,663 | -1,996 | -1,818 | -2,532 | — | — | — | — | — |
| Levered free cash flow | 2,126 | 21.4 | -1,292 | -2,589 | -1,316 | -804 | -853 | -596 | -505 | -508 |
Amounts in millions of TWD; per-share values in TWD; shares in millions.
| Item | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | 2,395 | 1,734 | 1,912 | 2,233 | 70.5 | 1,061 | 928 | 1,043 | 858 | -303 | -80.9 | 408 |
| Depreciation and amortization | 114 | 106 | 92.8 | 86.7 | 86.2 | 85.8 | 86.0 | 85.2 | 83.4 | 82.3 | 95.9 | 54.6 |
| Capital expenditure | -385 | -574 | -1,032 | -351 | -305 | -224 | -410 | -232 | -79.3 | -141 | -648 | -148 |
| Investing cash flow | -2,147 | -525 | -1,120 | -754 | -318 | -284 | -873 | -207 | -95.4 | -160 | -659 | -67.9 |
| Financing cash flow | 84.4 | -14.9 | 11.9 | -421 | -43.4 | -46.9 | 24.7 | -58.8 | -64.6 | -64.3 | -39.5 | -2,029 |
| Dividends paid | — | — | 0.0 | -366 | — | — | — | — | — | — | — | — |
| Share repurchases | — | — | — | — | — | — | — | — | — | — | -53.7 | -1,914 |
| Debt issued | — | — | 67.7 | -137 | — | — | — | — | — | — | 1.0 | — |
| Debt repaid | -55.8 | -56.6 | -124 | 81.1 | -58.0 | -59.0 | -59.5 | -59.3 | -65.6 | -69.8 | -49.6 | -173 |
| Effect of exchange rates | -36.4 | 288 | 307 | -260 | -961 | 253 | 140 | -5.9 | 171 | 53.9 | -87.6 | 179 |
| Net change in cash | 295 | 1,482 | 1,112 | 798 | -1,252 | 983 | 219 | 771 | 868 | -474 | -867 | -1,510 |
| Free cash flow | 2,010 | 1,160 | 881 | 1,883 | -234 | 837 | 517 | 811 | 778 | -444 | -729 | 260 |
| Levered free cash flow | 1,207 | 559 | 119 | 798 | 740 | 470 | 83.9 | 381 | 286 | -729 | -536 | -145 |
Financial statements of similar companies
Companies in the group: same industry, similar size
